0001213900-18-002859.txt : 20180313
0001213900-18-002859.hdr.sgml : 20180313
20180312191021
ACCESSION NUMBER: 0001213900-18-002859
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180313
DATE AS OF CHANGE: 20180312
EFFECTIVENESS DATE: 20180313
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001513525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 800667150
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-307524
FILM NUMBER: 18684857
BUSINESS ADDRESS:
STREET 1: 1180 SEMINOLE TRAIL
STREET 2: SUITE 495
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 434-422-9800
MAIL ADDRESS:
STREET 1: 1180 SEMINOLE TRAIL
STREET 2: SUITE 495
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C.
DATE OF NAME CHANGE: 20170515
FORMER COMPANY:
FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C.
DATE OF NAME CHANGE: 20110218
D
1
primary_doc.xml
X0708
D
LIVE
0001513525
ADIAL PHARMACEUTICALS, INC.
1180 SEMINOLE TRAIL
SUITE 495
CHARLOTTESVILLE
VA
VIRGINIA
22902
434-422-9800
DELAWARE
Adial Pharmaceuticals L.L.C.
ADial Pharmaceuticals, L.L.C.
Adial Pharmaceuticals, L.L.C.
Corporation
true
2017
William
B.
Stilley, III
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Director
Joseph
M.
Truluck
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Executive Officer
James
K.
Anderson
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Director
Robertson
H.
Gilliland
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Director
Bankole
A.
Johnson
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Director
James
W.
Newman, Jr.
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Director
Kevin
Schuyler, CFA
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Director
Tony
Goodman
1180 Seminole Trail, Suite 495
Charlottesville
VA
VIRGINIA
22901
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2018-02-23
false
true
true
true
Includes $100,000 of prior debt that exchanged for the debt and warrants
false
0
500000
500000
0
false
7
0
0
0
true
*Proceeds may be used to pay overhead and other corporate expenses which could include salaries
false
ADIAL PHARMACEUTICALS, INC.
/s/ William B. Stilley, III
William B. Stilley, III
Chief Executive Officer
2018-03-12